Dolci Giovanni M.
Known title: Chief Sales OfficerCIK: 0001801887
Associated companies
Transaction History
| IMAX | ▲ Buy | Option Exercise | 4,445 | $0 | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,682 | $0 | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 3,333 | $0 | 3/7/2026 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 4,918 | $201K | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Grant | 4,690 | $0 | 3/7/2026 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 2,205 | $90K | 3/7/2026 | View on chart |
| IMAX | ▼ Sell | Open Market | 6,188 | $212K | 11/10/2025 | View on chart |
| IMAX | ▼ Sell | Other | 6,188 | $139K | 11/10/2025 | View on chart |
| IMAX | ▼ Sell | Open Market | 6,500 | $162K | 8/5/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 4,445 | $0 | 3/7/2025 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 3,053 | $77K | 3/7/2025 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 5,095 | $129K | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 3,711 | $0 | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,680 | $0 | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Grant | 6,494 | $0 | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,276 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 3,711 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,680 | $0 | 3/7/2024 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 4,075 | $68K | 3/7/2024 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 1,871 | $31K | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Grant | 3,979 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,948 | $0 | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 1,934 | $0 | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,274 | $0 | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 3,711 | $0 | 3/7/2023 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 5,246 | $97K | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Grant | 5,159 | $0 | 3/7/2023 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 2,490 | $46K | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 1,752 | $0 | 12/1/2022 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 833 | $14K | 12/1/2022 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 1,458 | $0 | 3/7/2022 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,948 | $0 | 3/7/2022 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 1,933 | $0 | 3/7/2022 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 2,274 | $0 | 3/7/2022 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 4,094 | $74K | 3/7/2022 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 1,618 | $0 | 12/1/2021 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 769 | $12K | 12/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
IMAX Faces Disney Competition Amid Record Re-Release
IMAX stock is navigating a period where Disney is pushing its own big-screen format, creating competitive pressure. However, Wedbush analysts state there is no immediate threat from a potential Disney coalition. Meanwhile, the record-breaking re-release of 'The Odyssey' continues to support the company's investment case, even as the stock trades near its support level.
IMAX Faces Disney Competition Amid Record Re-Release. IMAX stock is navigating a period where Disney is pushing its own big-screen format, creating competitive pressure. However, Wedbush analysts state there is no immediate threat from a potential Disney coalition. Meanwhile, the record-breaking re-release of 'The Odyssey' continues to support the company's investment case, even as the stock trades near its support level.